Microvascular blood flow in the airway mucosa modulates bronchoconstriction.
Emala
Charles W
CW
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000818:Animals; D016084:Bronchoconstriction / Q000187:drug effects; D016085:Bronchoconstrictor Agents / Q000008:administration & dosage; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D055806:Microvessels / Q000294:innervation*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D009479:Neuropeptides / Q000008:administration & dosage; D012039:Regional Blood Flow; D020545:Respiratory Mucosa / Q000098:blood supply*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D014132:Trachea / Q000098:blood supply*; D014661:Vasoconstriction; D014664:Vasodilation; D014666:Vasomotor System / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D016085:Bronchoconstrictor Agents; D009479:Neuropeptides